Every material Form 8-K Neuraxis, INC has filed with the SEC since July 10, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Neuraxis's board declared a third-quarter 2026 dividend on its Series B Preferred Stock, payable in common stock rather than cash. About 81,339 common shares are expected to be issued, priced at $2.38 per share, with the payment due October 30, 2026 to holders of record as of October 26, 2026.
Dividend paid in common stock, based on accrued unpaid dividends from July 1, 2026 through the record date divided by $2.38
About 81,339 common shares expected to be issued
Fractional shares paid in cash at $2.38 per whole share
Payable October 30, 2026 to holders of record as of October 26, 2026
Neuraxis disclosed equity compensation actions taken in July and August 2026. A stock option exchange approved by stockholders on June 10, 2026 took effect July 24, swapping 1,319,394 options for an equal number of restricted stock units, and on August 13 the company granted new RSUs to four executives and one-time share awards to independent directors. The filing says the director awards address compensation that was below market levels, which adds to shareholder dilution.
Stock option exchange of 1,319,394 options into RSUs took effect July 24, 2026, vesting immediately for executives Brian Carrico, Adrian Miranda and Thomas Carrico.
On August 13, 2026, the company granted RSUs to Brian Carrico (193,329), Timothy Henrichs (141,479), Adrian Miranda (133,341) and Thomas Carrico (135,906), vesting in three equal annual installments.
On August 13, 2026, independent directors received a total of 127,120 shares of common stock as one-time awards for prior board service.
Neuraxis declared a second quarter 2026 dividend on its Series B Preferred Stock, to be paid in common stock rather than cash. The filing says about 80,463 common shares are expected to be issued, based on accrued dividends from April 1, 2026 divided by $2.38 per share.
About 80,463 shares of common stock are expected to be issued for the dividend.
Shares are calculated from accrued, unpaid dividends from April 1, 2026 through the record date, divided by $2.38.
Holders of record as of July 21, 2026 will receive the dividend on July 29, 2026.
Fractional shares will be paid in cash at $2.38 per share of Series B Preferred Stock.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Neuraxis, INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →